Vancomycin dosage regimens for pediatric patients.
作者信息
Nahata Milap C
机构信息
Colleges of Pharmacy and Medicine, The Ohio State University, Columbus, Ohio.
出版信息
J Pediatr Pharmacol Ther. 2009 Apr;14(2):64-5. doi: 10.5863/1551-6776-14.2.64.
Abstract
摘要
相似文献
1
Vancomycin dosage regimens for pediatric patients.儿科患者的万古霉素给药方案。
J Pediatr Pharmacol Ther. 2009 Apr;14(2):64-5. doi: 10.5863/1551-6776-14.2.64.
2
Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis.万古霉素剂量与囊性纤维化患儿血清谷浓度的关系。
Am J Health Syst Pharm. 2016 Jul 1;73(13):969-74. doi: 10.2146/ajhp150605.
3
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.评估万古霉素在儿科患者中的给药剂量和随后的血清浓度。
Ann Pharmacother. 2011 May;45(5):582-9. doi: 10.1345/aph.1P588. Epub 2011 Apr 26.
4
A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients.
Pediatr Infect Dis J. 1994 Nov;13(11):969-74. doi: 10.1097/00006454-199411000-00007.
5
How Much Vancomycin Dose Is Enough For The MRSA Infection in Pediatric Patients With Various Degrees of Renal Function?不同肾功能程度的儿科患者感染耐甲氧西林金黄色葡萄球菌时，多少万古霉素剂量才足够？
Iran J Pharm Res. 2019 Spring;18(2):995-1009. doi: 10.22037/ijpr.2019.1100654.
6
Vancomycin dosage in overweight and obese children.超重和肥胖儿童的万古霉素剂量。
Am J Health Syst Pharm. 2011 Nov 1;68(21):2062-8. doi: 10.2146/ajhp110107.
7
Use of Body Surface Area for Dosing of Vancomycin.使用体表面积来确定万古霉素的给药剂量。
J Pediatr Pharmacol Ther. 2019 Jul-Aug;24(4):296-303. doi: 10.5863/1551-6776-24.4.296.
8
Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.优化危重症儿童万古霉素剂量的药代动力学-药效学参数。
Pediatr Crit Care Med. 2011 Nov;12(6):e250-4. doi: 10.1097/PCC.0b013e3181fe4047.
9
Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review.儿科人群中万古霉素的使用、剂量及血清谷浓度：一项机构回顾性研究
Pharm Pract (Granada). 2017 Apr-Jun;15(2):887. doi: 10.18549/PharmPract.2017.02.887. Epub 2017 Jun 30.
10
Evaluation of predictability for vancomycin dosage regimens by the Bayesian method with Japanese population pharmacokinetic parameters.采用日本人群药代动力学参数的贝叶斯方法评估万古霉素给药方案的可预测性。
Biol Pharm Bull. 2002 Oct;25(10):1333-8. doi: 10.1248/bpb.25.1333.
引用本文的文献
1
Assessment of Antibiotic Resistance in Pediatric Infections: A Romanian Case Study on Pathogen Prevalence and Effective Treatments.儿科感染中抗生素耐药性的评估：罗马尼亚关于病原体流行情况及有效治疗方法的案例研究
Antibiotics (Basel). 2024 Sep 13;13(9):879. doi: 10.3390/antibiotics13090879.
本文引用的文献
1
Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.儿科患者万古霉素给药剂量与血清浓度的相关性：一项回顾性数据库综述。
J Pediatr Pharmacol Ther. 2009 Apr;14(2):86-93. doi: 10.5863/1551-6776-14.2.86.
2
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素最低抑菌浓度对耐甲氧西林金黄色葡萄球菌菌血症治疗的影响
Clin Infect Dis. 2008 Jan 15;46(2):193-200. doi: 10.1086/524667.
3
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.高剂量万古霉素治疗耐甲氧西林金黄色葡萄球菌感染：疗效与毒性
Arch Intern Med. 2006 Oct 23;166(19):2138-44. doi: 10.1001/archinte.166.19.2138.
4
Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus.用于确定金黄色葡萄球菌对万古霉素敏感性的断点降低的证据。
Antimicrob Agents Chemother. 2005 Sep;49(9):3982-3. doi: 10.1128/AAC.49.9.3982-3983.2005.
5
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.成人医院获得性肺炎、呼吸机相关性肺炎和医疗保健相关性肺炎管理指南。
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416. doi: 10.1164/rccm.200405-644ST.
6
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素治疗耐甲氧西林金黄色葡萄球菌菌血症时的最低抑菌浓度（MIC）和杀菌活性与疗效的关系。
J Clin Microbiol. 2004 Jun;42(6):2398-402. doi: 10.1128/JCM.42.6.2398-2402.2004.
7
Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.万古霉素治疗药物监测在患者中的临床疗效
Biol Pharm Bull. 2003 Jun;26(6):876-9. doi: 10.1248/bpb.26.876.
8
Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.新生儿中万古霉素相关肾毒性的缺失：一项病例对照研究。
Pediatrics. 1999 Apr;103(4):e48. doi: 10.1542/peds.103.4.e48.
9
Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.接受万古霉素和氨基糖苷类药物联合治疗的儿科患者未出现肾毒性。
Chemotherapy. 1987;33(4):302-4. doi: 10.1159/000238512.
Zotero 插件